Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013;2013:320176.
doi: 10.1155/2013/320176. Epub 2013 Feb 27.

A Comparison Between Revised NCEP ATP III and IDF Definitions in Diagnosing Metabolic Syndrome in an Urban Sri Lankan Population: The Ragama Health Study

Affiliations
Free PMC article

A Comparison Between Revised NCEP ATP III and IDF Definitions in Diagnosing Metabolic Syndrome in an Urban Sri Lankan Population: The Ragama Health Study

S Chackrewarthy et al. ISRN Endocrinol. .
Free PMC article

Abstract

Background. The prevalence of metabolic syndrome (MetS) within individual cohorts varies with the definition used. The aim of this study was to compare the prevalence of MetS between IDF and revised NCEP ATP III criteria in an urban Sri Lankan population and to investigate the characteristics of discrepant cases. Methods. 2985 individuals, aged 35-65 years, were recruited to the study. Anthropometric and blood pressure measurements and laboratory investigations were carried out following standard protocols. Results. Age and sex-adjusted prevalences of MetS were 46.1% and 38.9% by revised NCEP and IDF definitions, respectively. IDF criteria failed to identify 21% of men and 7% of women identified by the revised NCEP criteria. The discrepant group had more adverse metabolic profiles despite having a lower waist circumference than those diagnosed by both criteria. Conclusion. MetS is common in this urban Sri Lankan cohort regardless of the definition used. The revised NCEP definition was more appropriate in identifying the metabolically abnormal but nonobese individuals, especially among the males predisposed to type 2 diabetes or cardiovascular disease. Further research is needed to determine the suitability of the currently accepted Asian-specific cut-offs for waist circumference in Sri Lankan adults.

Figures

Figure 1
Figure 1
Gender-specific crude prevalences of metabolic syndrome categorized by glycaemic status (NFG: normal fasting glucose, IFG: impaired fasting glucose, and DM: diabetes mellitus).
Figure 2
Figure 2
Gender-specific prevalences of components of MetS categorized by glycaemic status (NFG: normal fasting glucose, IFG: impaired fasting glucose, and DM: diabetes mellitus).

Similar articles

See all similar articles

Cited by 11 articles

See all "Cited by" articles

References

    1. Grundy SM. Metabolic syndrome pandemic. Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28(4):629–636. - PubMed
    1. Grundy SM. Metabolic syndrome: a multiplex cardiovascular risk factor. Journal of Clinical Endocrinology and Metabolism. 2007;92(2):399–404. - PubMed
    1. Enas EA, Mohan V, Deepa M, Farooq S, Pazhoor S, Chennikkara H. The metabolic syndrome and dyslipidemia among Asian Indians: a population with high rates of diabetes and premature coronary artery disease. Journal of the Cardiometabolic Syndrome. 2007;2(4):267–275. - PubMed
    1. Reaven G. Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease. Circulation. 2002;106(3):286–288. - PubMed
    1. Pollex RL, Hegele RA. Genetic determinants of the metabolic syndrome. Nature Clinical Practice Cardiovascular Medicine. 2006;3(9):482–489. - PubMed

LinkOut - more resources

Feedback